<DOC>
	<DOCNO>NCT00193700</DOCNO>
	<brief_summary>Measure evaluate level testosterone blood , determine safety tolerability follow daily application testosterone gel . Subjects complete trial may participate extension part ( UMD-01-080E ) .</brief_summary>
	<brief_title>Pharmacokinetic Evaluation Testosterone Gel ( 1 % )</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Diagnosis primary secondary hypogonadism constitutional delay growth puberty ( CDGP ) Clinically significant uncontrolled medical condition psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Hypogonadism</keyword>
</DOC>